Venus Remedies [VENUSREM] vs Medico Remedies [MEDICO] Detailed Stock Comparison

Venus Remedies

NSE
Loading...

Medico Remedies

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Venus Remedies wins in 14 metrics, Medico Remedies wins in 5 metrics, with 0 ties. Venus Remedies appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricVenus RemediesMedico RemediesBetter
P/E Ratio (TTM)11.4431.92Venus Remedies
Price-to-Book Ratio1.095.30Venus Remedies
Debt-to-Equity Ratio0.3023.53Venus Remedies
PEG Ratio0.022.02Venus Remedies
EV/EBITDA6.9123.33Venus Remedies
Profit Margin (TTM)8.00%6.52%Venus Remedies
Operating Margin (TTM)2.97%5.38%Medico Remedies
EBITDA Margin (TTM)2.97%5.38%Medico Remedies
Return on Equity8.08%16.16%Medico Remedies
Return on Assets (TTM)6.33%8.43%Medico Remedies
Free Cash Flow (TTM)$683.65M$17.05MVenus Remedies
1-Year Return31.25%-12.63%Venus Remedies
Price-to-Sales Ratio (TTM)0.922.09Venus Remedies
Enterprise Value$4.59B$3.40BVenus Remedies
EV/Revenue Ratio0.682.15Venus Remedies
Gross Profit Margin (TTM)43.78%28.53%Venus Remedies
Revenue per Share (TTM)$501$19Venus Remedies
Earnings per Share (Diluted)$40.15$1.25Venus Remedies
Beta (Stock Volatility)0.400.03Medico Remedies
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Venus Remedies vs Medico Remedies Stock Performance Analysis

Loading Price Chart...

Venus Remedies
Medico Remedies
Venus Remedies Stock Overview | Medico Remedies Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Venus Remedies-0.60%2.09%-3.28%4.94%55.76%45.92%
Medico Remedies-0.64%-3.09%-0.13%-22.33%-34.84%-31.31%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Venus Remedies31.25%118.56%246.55%278.76%45.01%17.56%
Medico Remedies-12.63%-64.61%-70.53%-70.53%-70.53%-70.53%

News Based Sentiment: Venus Remedies vs Medico Remedies

Venus Remedies

News based Sentiment: MIXED

Venus Remedies reported impressive Q1 FY2026 results, driving share price increases and attracting institutional investment. However, analyst forecasts suggest a potential price drop, and the stock is trading at a significant premium to its intrinsic value, creating a mixed investment outlook.

View Venus Remedies News Sentiment Analysis

Medico Remedies

News based Sentiment: MIXED

Medico Remedies reported positive financial results for the June quarter, but these gains are counterbalanced by a declining stock evaluation, a decrease in promoter stake, and a leadership change. This creates a mixed investment picture with both opportunities and risks, making it a significant month for the company.

View Medico Remedies News Sentiment Analysis

Performance & Financial Health Analysis: Venus Remedies vs Medico Remedies

MetricVENUSREMMEDICO
Market Information
Market Cap i₹6.24B₹3.29B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i11,741241,214
90 Day Avg. Volume i12,650205,322
Last Close₹461.75₹38.98
52 Week Range₹270.25 - ₹567.80₹37.18 - ₹79.83
% from 52W High-18.68%-51.17%
All-Time High₹639.00 (Aug 09, 2021)₹365.05 (Mar 06, 2023)
% from All-Time High-27.74%-89.32%
Growth Metrics
Quarterly Revenue Growth0.21%0.24%
Quarterly Earnings Growth6.87%0.15%
Financial Health
Profit Margin (TTM) i0.08%0.07%
Operating Margin (TTM) i0.03%0.05%
Return on Equity (TTM) i0.08%0.16%
Debt to Equity (MRQ) i0.3023.53
Cash & Liquidity
Book Value per Share (MRQ)₹419.65₹7.53
Cash per Share (MRQ)₹116.93₹0.31
Operating Cash Flow (TTM) i₹883.16M₹-3,720,000
Levered Free Cash Flow (TTM) i₹453.15M₹100.93M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Venus Remedies vs Medico Remedies

MetricVENUSREMMEDICO
Price Ratios
P/E Ratio (TTM) i11.4431.92
Forward P/E iN/AN/A
PEG Ratio i0.022.02
Price to Sales (TTM) i0.922.09
Price to Book (MRQ) i1.095.30
Market Capitalization
Market Capitalization i₹6.24B₹3.29B
Enterprise Value i₹4.59B₹3.40B
Enterprise Value Metrics
Enterprise to Revenue i0.682.15
Enterprise to EBITDA i6.9123.33
Risk & Other Metrics
Beta i0.400.03
Book Value per Share (MRQ) i₹419.65₹7.53

Financial Statements Comparison: Venus Remedies vs Medico Remedies

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)VENUSREMMEDICO
Revenue/Sales i₹1.32B₹382.52M
Cost of Goods Sold i₹741.50M₹273.39M
Gross Profit i₹577.50M₹109.13M
Research & Development i₹39.90MN/A
Operating Income (EBIT) i₹39.20M₹20.57M
EBITDA i₹187.90M₹34.84M
Pre-Tax Income i₹126.00M₹24.34M
Income Tax i₹30.10M₹6.16M
Net Income (Profit) i₹95.90M₹18.18M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)VENUSREMMEDICO
Cash & Equivalents i₹575.23M₹10.95M
Total Current Assets i₹4.52B₹966.75M
Total Current Liabilities i₹1.36B₹569.62M
Long-Term Debt i₹0₹3.69M
Total Shareholders Equity i₹5.61B₹624.69M
Retained Earnings i₹2.15B₹423.00M
Property, Plant & Equipment i₹1.07B₹5.73M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)VENUSREMMEDICO
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVENUSREMMEDICO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i11,741241,214
Average Daily Volume (90 Day) i12,650205,322
Shares Outstanding i13.37M82.98M
Float Shares i6.79M17.69M
% Held by Insiders i0.50%0.70%
% Held by Institutions i0.01%0.00%

Dividend Analysis & Yield Comparison: Venus Remedies vs Medico Remedies

MetricVENUSREMMEDICO
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i₹0.00N/A
Ex-Dividend DateN/AN/A